Raymond Swanson

Dr. Raymond Swanson

orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
CECarole Escartin
Carole Escartin
EGElena Galea
Elena Galea
ALAndrás Lakatos
András Lakatos
JOJames P. O’cAllaghan
James P. O’cAllaghan
GPGabor C. Petzold
Gabor C. Petzold
Alexei VerkhratskyAlexei Verkhratsky
Alexei Verkhratsky

1 March 1990 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
RSRaymond Swanson
Raymond Swanson
MMMatthew T. Morton
Matthew T. Morton
GTGeorge Tsao-Wu
George Tsao-Wu
RSRobert A. Savalos
Robert A. Savalos
CDCharisse Davidson
Charisse Davidson
FSFrank R. Sharp
Frank R. Sharp
An accurate, reproducible method for determining the infarct volumes of gray matter structures is presented for use with presently available image analysis systems. Areas of stained sections with optical densities above that of a threshold value are automatically recognized and measured. This eliminates the potential error and bias inherent in manually delineating infarcted regions. Moreover, the volume of surviving normal gray matter is determined rather than that of the infarct. This approach minimizes the error that is introduced by edema, which distorts and enlarges the infarcted tissue and surrounding white matter.

7 June 2009 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
ABAngela M Brennan
Angela M Brennan
SSSang Won Suh
Sang Won Suh
SWSeok Joon Won
Seok Joon Won
PNPurnima Narasimhan
Purnima Narasimhan
TKTiina M Kauppinen
Tiina M Kauppinen
RSRaymond Swanson
Raymond Swanson

27 November 2005 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
KAKoji Aoyama
Koji Aoyama
SSSang Won Suh
Sang Won Suh
AHAaron M Hamby
Aaron M Hamby
JLJialing Liu
Jialing Liu
WCWai Yee Chan
Wai Yee Chan
RSRaymond Swanson
Raymond Swanson

24 February 2010 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
CAConrad C. Alano
Conrad C. Alano
PGPhilippe Garnier
Philippe Garnier
WYWeihai Ying
Weihai Ying
YHYouichirou Higashi
Youichirou Higashi
TKTiina M. Kauppinen
Tiina M. Kauppinen
RSRaymond Swanson
Raymond Swanson
Poly(ADP-ribose)-1 (PARP-1) is a key mediator of cell death in excitotoxicity, ischemia, and oxidative stress. PARP-1 activation leads to cytosolic NAD+depletion and mitochondrial release of apoptosis-inducing factor (AIF), but the causal relationships between these two events have been difficult to resolve. Here, we examined this issue by using extracellular NAD+to restore neuronal NAD+levels after PARP-1 activation. Exogenous NAD+was found to enter neurons through P2X7-gated channels. Restoration of cytosolic NAD+by this means prevented the glycolytic inhibition, mitochondrial failure, AIF translocation, and neuron death that otherwise results from extensive PARP-1 activation. Bypassing the glycolytic inhibition with the metabolic substrates pyruvate, acetoacetate, or hydroxybutyrate also prevented mitochondrial failure and neuron death. Conversely, depletion of cytosolic NAD+with NAD+glycohydrolase produced a block in glycolysis inhibition, mitochondrial depolarization, AIF translocation, and neuron death, independent of PARP-1 activation. These results establish NAD+depletion as a causal event in PARP-1-mediated cell death and place NAD+depletion and glycolytic failure upstream of mitochondrial AIF release.

1 March 2004 in Current Molecular Medicine
Verified
Journal Article
Closed access
RSRaymond Swanson
Raymond Swanson
WYWeihai Ying
Weihai Ying
TKTiina Kauppinen
Tiina Kauppinen
Glutamate excitotoxicity,oxidative stress,and acidosis are primary mediators of neuronal death during ischemia and reperfusion.Astrocytes influence these processes in several ways. Glutamate uptake by astrocytes normally prevents excitotoxic glutamate elevations in brain extracellular space,and this process appears to be a critical determinant of neuronal survival in the ischemic penumbra.Conversely,glutamate efflux from astrocytes by reversal of glutamate uptake, volume sensitive organic ion channels,and other routes may contribute to extracellular glutamate elevations.Glutamate activation of neuronal N-methyl-D-aspartate (NMDA)receptors is modulated by glycine and D-serine:both of these neuromodulators are transported by astrocytes,and D-serine production is localized exclusively to astrocytes.Astrocytes influence neuronal antioxidant status through release of ascorbate and uptake of its oxidized form,dehydroascorbate,and by indirectly supporting neuronal glutathione metabolism.In addition,glutathione in astrocytes can serve as a sink for nitric oxide and thereby reduce neuronal oxidant stress during ischemia.Astrocytes probably also influence neuronal survival in the post-ischemic period.Reactive astrocytes secrete nitric oxide, TNF α ,matrix metalloproteinases,and other factors that can contribute to delayed neuronal death,and facilitate brain edema via aquaporin-4 channels localized to the astrocyte endfoot-endothelial interface.On the other hand erythropoietin,a paracrine messenger in brain,is produced by astrocytes and upregulated after ischemia.Erythropoietin stimulates the Janus kinase-2 (JAK-2)and nuclear factor-kappaB (NF-kB)signaling pathways in neurons to prevent programmed cell death after ischemic or excitotoxic stress.Astrocytes also secrete several angiogenic and neurotrophic factors that are important for vascular and neuronal regeneration after stroke.